Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example.

about

Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example.

Item

http://www.wikidata.org/entity/Q38612393

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example.

@en

type

Item

label

Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example.

@en

prefLabel

Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example.

@en

P1476

Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example

@en

P2093

An-Wen Chan

http://www.w3.org/2001/XMLSchema#string

Craig Rodrigues

http://www.w3.org/2001/XMLSchema#string

Jerry H Gurwitz

http://www.w3.org/2001/XMLSchema#string

Manpreet Lamba

http://www.w3.org/2001/XMLSchema#string

Nathan Herrmann

http://www.w3.org/2001/XMLSchema#string

Nishila Mehta

http://www.w3.org/2001/XMLSchema#string

Robin Mason

http://www.w3.org/2001/XMLSchema#string

Sudeep S Gill

http://www.w3.org/2001/XMLSchema#string

Susan E Bronskill

http://www.w3.org/2001/XMLSchema#string

Suzanne Day

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

Biomedical research: increasing value, reducing waste

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial

Does a change in health research funding policy related to the integration of sex and gender have an impact?

Increasing value and reducing waste: addressing inaccessible research

Dementia before death in ageing societies--the promise of prevention and the reality

Comparison of evidence of treatment effects in randomized and nonrandomized studies.

Published randomized controlled trials of drug therapy for dementia often lack complete data on harm.

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

P304

2213-2219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JGS.15020

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paula Rochon

P577

2017-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28832937

http://www.w3.org/2001/XMLSchema#string